Telemetry Investments, L.L.C. Verastem, Inc. Transaction History
Telemetry Investments, L.L.C.
- $63.3 Million
- Q4 2022
A detailed history of Telemetry Investments, L.L.C. transactions in Verastem, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 225,000 shares of VSTM stock, worth $891,000. This represents 0.14% of its overall portfolio holdings.
Number of Shares
225,000
Previous 187,500
20.0%
Holding current value
$891,000
Previous $159,000
42.77%
% of portfolio
0.14%
Previous 0.2%
Shares
15 transactions
Others Institutions Holding VSTM
# of Institutions
5Shares Held
297KCall Options Held
0Put Options Held
0-
Beaumont Financial Partners, LLC48KShares$190,0800.0% of portfolio
-
Eaton Vance Management Boston, MA20KShares$79,2000.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.99KShares$11,8200.0% of portfolio
-
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L21.07KShares$4,2530.0% of portfolio
About Verastem, Inc.
- Ticker VSTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 210,000,000
- Market Cap $832M
- Description
- Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...